Piper Sandler raises Nevro stock to Neutral, cuts target to $5.85
Piper Sandler analyst Adam Maeder upgraded shares of Nevro Corp (NYSE:NVRO), a medical device company with a market ...
Piper Sandler announces share repurchase authorization for up to $150M
Piper Sandler (PIPR) announced that its board of directors has authorized the repurchase of up to $150 million of the company’s outstanding ...
Piper Sandler raises Shore Bancshares target to $20, cites growth potential
Piper Sandler analyst Justin Crowley initiated coverage on Shore Bancshares (NASDAQ:SHBI) with an Overweight rating, setting a price target of $20.00. The firm highlighted the bank's strong presence ...